When was ApoCell founded?

ApoCell was founded in 2004 and raised its 1st funding round 5 years after it was founded.

Where is ApoCell located?

ApoCell is headquartered in Houston, United States. It is registered at Bethesda, Maryland.

Who is the current CEO of ApoCell?

Darren W Davis and Mark Clein s of ApoCell. Mark Clein has also founded 1 company.

How many employees does ApoCell have?

As of May 31, 2026, the latest employee count at ApoCell is 5.

Is ApoCell a funded company?

ApoCell is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Sep 16, 2009.

When was the latest funding round of ApoCell?

ApoCell's latest funding was a $***** Seed round on Sep 16, 2009, with participation from 1 investor.

Where does ApoCell rank among its competitors?

ApoCell ranks 107th amongst 341 active competitors, of which 15 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Dash Bio, which secured $11M in Jun, 2025.

Who are the top competitors of ApoCell?

ApoCell's top competitors include Solvias, BioAgilytix and Advion. Among them, Dash Bio secured the most recent funding round in June, 2025.

ApoCell - 2026 Company Profile, Team, Funding & Competitors

ApoCell is an acquired company based in Houston (United States), founded in 2004 by Darren W Davis. It operates as a Provider of clinical trial and clinical development on bioanalytical services. ApoCell has raised an undisclosed amount in funding. The company has 341 active competitors, including 15 funded and 86 that have exited. Its top competitors include companies like Solvias, BioAgilytix and Advion.

Company Details

ApoCell is a provider of tools for molecular profiling and diagnostics of tumor cells. It provides tools for molecular profiling and diagnostics for the biopharma industry and other translational medical groups. The company specializes in rare cell analysis, specifically in characterizing circulating tumor cells. It has developed ApoStream that distinguish CTCs from healthy blood cells through dielectrophoresis (DEP) and microfluidics. In addition, the company also provides services for functional biomarker analysis, single-cell protein analysis, and other traditional genomic analyses. ApoCell conducts sample analyses for clinical trials and also develops assays for the same.

Website: apocell.com
Social
Registered Address: Bethesda, Maryland

Key Metrics

Founded Year

2004

Location

Houston, United States

Stage

Acquired

Latest Funding Round

Seed, Sep 16, 2009, $*****

Investors

Summit Partners

Ranked

107^th among 341 active competitors

Employee Count

5 as on May 31, 2026

Similar Companies

Solvias & 374 more

Exit Details

Acquired by Precision Medicine Group (Oct 16, 2018)

View ApoCell's full profile

ApoCell is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Precision Medicine Group, LLC CIN: 452969432 , United States, Active	Dec 31, 1999	-	2174 (As on Dec 31, 2024)	-
APOCELL, INC. CIN: 161719463 , United States, Active	Dec 31, 1999	-	6 (As on Dec 31, 2018)	-

ApoCell got acquired by Precision Medicine Group on Oct 16, 2018.

Click here to take a look at ApoCell's acquisition in detail

ApoCell has raised funding over 1 round. Its latest funding round was a Seed round on Sep 16, 2009 for $*****. 1 investor participated in its latest round. ApoCell has 1 institutional investor.

Here is the list of recent funding rounds of ApoCell:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 16, 2009	1667401	Seed	8534287	4897593	2788439	6694705

Access funding benchmarks and valuations. Sign up today!

View details of ApoCell's funding rounds and investors

The founders of ApoCell is Darren W Davis. Mark Clein is the CEO of ApoCell.

Here are the details of ApoCell's key team members:

Darren W Davis: Former Founder & CEO of ApoCell.
Mark Clein: Co-Founder of ApoCell and founder of 2 other companies, Precision Medicine Group and Precision for Medicine.

View details of ApoCell's Founder profiles and Board Members

ApoCell's employee count trend

ApoCell has 5 employees as of May 26. Here is ApoCell's employee count trend over the years:

Uncover ApoCell's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ApoCell include Solvias, BioAgilytix and Advion. Here is the list of Top 10 competitors of ApoCell, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Solvias 1999, Kaiseraugst (Switzerland), Acquired	Developer and manufacturer of medical devices, cosmetics, agrochemicals, and chemicals	-	Water Street, Broadoak Capital Partners & 1 others	59/100
2nd	BioAgilytix 2008, Durham (United States), Acquired	Global bioanalytical services leader, supporting drug development across various modalities	-	GHO Capital Partners, Caledonia Private Capital ... & 2 others	57/100
3rd	Advion 1993, Ithaca (United States), Acquired	Mass spectrometry, chromatography, and purification solutions for scientific advancement	$45.6M	Gefinor Capital, Aisling Capital & 3 others	50/100
4th	Dash Bio 2024, Boston (United States), Series A	Provider of automated bioanalysis platform for accelerated clinical drug development	$17.5M	The Aligned Fund, Freestyle & 5 others	48/100
5th	ImmunXperts 2014, Charleroi (Belgium), Acquired	CRO specializing in human immune system based bioassay development services	$1M	Biowin, Sambrinvest	48/100
6th	Nucro-Technics 1970, Scarborough (Canada), Acquired	Full-service bioanalytical CRO offering toxicity, bioanalytical and stability study services	-	-	47/100
7th	Teena Biolabs 1999, Hyderabad (India), Acquired	Testing laboratory offering pharmacopeial tests, calibration & validation services	-	-	46/100
8th	Nordic Bioscience 1996, Herlev (Denmark), Late Stage	Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform	-	KKR, Europa	46/100
9th	Sitec Labs 2004, Mumbai (India), Unfunded	CRO offering bioequivalence and bioanalytical services	-	-	45/100
10th	Alderley Analytical 2013, Stockport (United Kingdom), Acquired	Provider of bioanalytical services for drug development programs and testing	$869K	Pioneer Group, Northern Powerhouse Investment Fund ... & 3 others	45/100
107th	ApoCell 2004, Houston (United States), Acquired	Provider of clinical trial and clinical development on bioanalytical services	-	Summit Partners	28/100